Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.

Canda, AE; Tuzel, E; Mungan, MEHMET; Yorukoglu, K; Kirkali, Z

doi:10.1016/j.eururo.2003.12.014

Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.

Atıf İçin Kopyala

Canda A., Tuzel E., Mungan M. U., Yorukoglu K., Kirkali Z.

European urology, cilt.45, sa.4, 2004 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 45 Sayı: 4
Basım Tarihi: 2004
Doi Numarası: 10.1016/j.eururo.2003.12.014
Dergi Adı: European urology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: bladder, transitional cell carcinoma, prostatic urethral involvement, carcinoma in situ, BCG, intravesical treatment, BACILLUS-CALMETTE-GUERIN, INTRAVESICAL BCG, CANCER, THERAPY, INSITU, IMMUNOTHERAPY
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: Treatment of patients with mucosal prostatic urethral transitional cell carcinoma (TCC) is controversial. In this study, we evaluated the outcome of patients with mucosal prostatic urethral TCC who were managed conservatively.